Sysmex Corp
TSE:6869

Watchlist Manager
Sysmex Corp Logo
Sysmex Corp
TSE:6869
Watchlist
Price: 3 177 JPY 1.44% Market Closed
Market Cap: 2T JPY
Have any thoughts about
Sysmex Corp?
Write Note

Sysmex Corp
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sysmex Corp
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sysmex Corp
TSE:6869
Net Income (Common)
ÂĄ53.5B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
8%
Terumo Corp
TSE:4543
Net Income (Common)
ÂĄ119.5B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
13%
Olympus Corp
TSE:7733
Net Income (Common)
ÂĄ16.6B
CAGR 3-Years
-22%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
Nihon Kohden Corp
TSE:6849
Net Income (Common)
ÂĄ14B
CAGR 3-Years
-14%
CAGR 5-Years
7%
CAGR 10-Years
2%
JEOL Ltd
TSE:6951
Net Income (Common)
ÂĄ25.1B
CAGR 3-Years
66%
CAGR 5-Years
34%
CAGR 10-Years
21%
Fukuda Denshi Co Ltd
TSE:6960
Net Income (Common)
ÂĄ18.2B
CAGR 3-Years
5%
CAGR 5-Years
14%
CAGR 10-Years
11%
No Stocks Found

Sysmex Corp
Glance View

Market Cap
2T JPY
Industry
Health Care

Sysmex Corporation, a global leader in healthcare and diagnostics, specializes in innovative laboratory solutions and instruments that enhance patient care and streamline clinical workflows. Established in 1968 and headquartered in Kobe, Japan, Sysmex has evolved from a domestic player to an international powerhouse, with a presence in over 190 countries. With a steadfast commitment to research and development, the company focuses on hematology, immunochemistry, and molecular diagnostics, continually pushing the boundaries of technology. Their flagship products, which include advanced analyzers and systems, empower healthcare professionals to make timely and accurate clinical decisions, ultimately improving patient outcomes across the globe. For investors, Sysmex embodies a compelling growth story in the ever-expanding healthcare market. The aging population and increasing prevalence of chronic diseases drive demand for diagnostic solutions, positioning Sysmex to capitalize on these trends. The company’s robust financial performance is evidenced by consistent revenue growth and a strong balance sheet, supported by strategic collaborations and a diverse product portfolio. With a commitment to sustainability and social responsibility, Sysmex not only prioritizes profitability but also aims to contribute positively to global health challenges. As the world increasingly relies on advanced diagnostics, Sysmex stands out as a forward-thinking investment opportunity that combines financial stability with a meaningful social impact.

Intrinsic Value
2 973.08 JPY
Overvaluation 6%
Intrinsic Value
Price

See Also

What is Sysmex Corp's Net Income (Common)?
Net Income (Common)
53.5B JPY

Based on the financial report for Sep 30, 2024, Sysmex Corp's Net Income (Common) amounts to 53.5B JPY.

What is Sysmex Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
8%

Over the last year, the Net Income (Common) growth was 22%. The average annual Net Income (Common) growth rates for Sysmex Corp have been 9% over the past three years , 6% over the past five years , and 8% over the past ten years .

Back to Top